|
|
|
|
|
| |Product Pipeline |Product Portfolio   |
| Cardiovascular Diseases | Central Nervous System Disorders | Infectious Diseases | | Arthritis/Inflammation | Metabolic Diseases | Allergic Diseases | | Cancer | Genitourinary/Sexual Health | Surgery/Interventional | | Consumer Health/OTC | Animal Health | | |
| ||
| MAJOR PFIZER PRODUCTS AND SELECTED CANDIDATES IN DEVELOPMENT | ||
| Arthritis/Inflammation | ||
| Current Products | ||
| Feldene Feldene FDDF [I] Flucam [I] Command hip and Monogram knee instrument systems |
Duracon, Interax [I] Kinemax total knee systems Duration Stabilized Polyethylene Components |
Exeter total hip Hydroxyapatite coatings for orthopedic implants Partnership and ABG [I] total hip systems Simplex P bone cement |
| Extensions / Additional Indications (last 12 months) | Under Regulatory Review | In Advanced-Stage Development |
|
Celebra (celecoxib) 5 (for osteo- and rheumatoid arthritis, and pain) ChiroDrive [U.S.] New External Fixation Systems New IM Nail Systems New Plating Systems New Spinal Systems | ||
| Key: [U.S.]—U.S. only [I]—International only (in at least one country) No Key—Both U.S. and at least one other country 5Discovered and developed by G.D. Searle & Co., a division of Monsanto; copromoted by Searle and Pfizer | ||
|
|
|
| ||||
 |
 |
 |
 | |
| ||||
 |
||||
 |
||||
| Advisory Information for Investors | ||||
| Copyright © 1997, 1998 Pfizer Inc All rights reserved. | ||||
| ||||